StockDrifts LogoStockDrifts

Pamtech 271830

Company
팸텍Pamtech
Insiders
3
Buys
1
Total Value
₩284M ($197K)
Avg Return
+17.59%
Last Filing
2025-07-16

Pamtech (271830) has 1 disclosed insider purchases and 11 disclosed disposals on record, filed by 3 distinct insiders. Together those filings cover ₩284M ($197K) in reported transaction value. The earliest filing StockDrifts holds for Pamtech is dated 2024-03-29; the most recent is 2025-07-16. All of it is parsed from DART D001/D002 insider disclosures, the official disclosure system operated by the Financial Supervisory Service (Korea). Across these filings the average return since disclosure is +17.59%, measured from each filing date to the latest available close.

Price & insider activity (12 months)

Recent insider trades

DateTypeSourceInsiderPositionSharesPrice at filingReturnValue
2025-07-16SELLMarket Sell
이인호
Inho Lee
Managing Director-6.0K₩1,829+9.6%₩11M ($8K)
2025-07-15SELLMarket Sell
이인호
Inho Lee
Managing Director-33₩1,824+9.3%₩60K ($42)
2025-07-14SELLMarket Sell
이인호
Inho Lee
Managing Director-11.0K₩1,758+5.9%₩19M ($13K)
2025-01-07BUYMarket Buy
이영록
Youngrok Lee
Managing Director6.2K₩1,699-2.6%₩10M ($7K)
2024-12-30SELLMarket Sell
이영규
Younggyu Lee
Managing Director-30.3K₩1,571-5.3%₩48M ($33K)
2024-12-27SELLMarket Sell
이영규
Younggyu Lee
Managing Director-1.0K₩1,559-6.1%₩2M ($1K)
2024-12-26SELLMarket Sell
이영규
Younggyu Lee
Managing Director-3.7K₩1,586-4.3%₩6M ($4K)
2024-08-08SELLMarket Sell
이영규
Younggyu Lee
Managing Director-15.0K₩2,150+23.1%₩32M ($22K)
2024-08-07SELLMarket Sell
이영규
Younggyu Lee
Managing Director-20.0K₩2,155+23.3%₩43M ($30K)
2024-04-02SELLMarket Sell
이인호
Inho Lee
Managing Director-2.9K₩3,470+52.3%₩10M ($7K)
2024-04-01SELLMarket Sell
이인호
Inho Lee
Managing Director-23.0K₩3,550+53.4%₩82M ($57K)
2024-03-29SELLMarket Sell
이인호
Inho Lee
Managing Director-6.0K₩3,485+52.5%₩21M ($15K)

Frequently asked questions

Who has been buying Pamtech stock?
3 distinct insiders have filed 1 disclosed insider purchases in Pamtech (271830), most recently on 2025-07-16. Each filer, their role, the number of shares and the price at filing are listed in the table on this page.
How many insider filings does Pamtech have?
Pamtech has 1 buy-side and 11 sell-side disclosures on record, covering ₩284M ($197K) in total reported value, spanning 2024-03-29 to 2025-07-16.
Where does StockDrifts get Pamtech insider data?
From DART D001/D002 insider disclosures — the official filing system run by the Financial Supervisory Service (Korea). StockDrifts parses each disclosure and matches it to daily price history; the original filings remain available directly from DART.
Do insider buys in Korean stocks predict returns?
Not uniformly. StockDrifts analysed 170,720 share-count changes across 56,930 Korean DART filings using cross-sectional alpha at fixed forward horizons, and found returns concentrated in particular signal tiers rather than in insider buying generally.

Source filings

Every trade listed above is disclosed in DART D001/D002 insider disclosures, filed with the Financial Supervisory Service (Korea). View the original DART filings for Pamtech. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.